The Five W's of Holding Your First, First-in-Human Trial
Jul 
22
 | 
9:30am

Melinda Richter

Global Head of JLABS, Johnson & Johnson Innovation

Moderator

As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.


By providing infrastructure, services, educational programs and networks in global hotspots, JLABS is the best place to start a company working in healthcare, with a specific emphasis on Johnson & Johnson’s sectors: consumer, medical device and pharmaceuticals.

Follow Melinda on LinkedIn

Dr. Arjun Desai

Chief Operating Officer

Panelist

9:30am–10:00am

Registration Opens, Networking & Introductions

Agenda

This is a one-day event happening from 9:30AM to 10:00AM on July 22, 2018.

Nilesh Kumar

Partner, Novo Ventures

As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.

Speakers
Agenda
Venue
Ticket Sales Are Closed
Text goes here
X
July 
22
, 
2018
9:30am
–
2:00pm
The Five W's of Holding Your First, First-in-Human Trial

Who, what, when, where and why to hold your first, first-in-human clinical trial? We've tapped into experts in the field from Johnson & Johnson, CROs and agencies to help you answer these questions and more!

You’ve answered some basic science questions about a medical devices’s safety and are ready to move to the clinic. There is a lot to consider including study design, cost/incentives, speed, quality, the participant pool, communication/language, partners, your market, standard of medical care, data integrity and more! To answer these questions, we've assembled a group of experts to help you prepare before you take the next steps.

Read more about us
Text goes here
X

At a Glance

Agenda

This is a one-day event happening from 9:30AM to 10:00AM on July 22, 2018.

Speakers

Melinda Richter, Dr. Arjun Desai, Diana Rhie, and Neema Saless

Melinda Richter

Global Head of JLABS, Johnson & Johnson Innovation

Moderator

As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.


By providing infrastructure, services, educational programs and networks in global hotspots, JLABS is the best place to start a company working in healthcare, with a specific emphasis on Johnson & Johnson’s sectors: consumer, medical device and pharmaceuticals.

Follow Melinda on LinkedIn

Speakers

Dr. Arjun Desai

Chief Operating Officer

Panelist

Dr. Arjun Desai

Chief Operating Officer

Panelist

Dr. Arjun Desai

Chief Operating Officer

Panelist

Speakers

Morgan Farrar Brown

Associate Director of Clinical Partnerships,

Texas Medical Center

As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.

P. LaMont Bryant, PhD

Vice President, Regulatory Affairs

Ethicon, Inc.

As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.

Shrojal Desai, PhD

Senior Director, Preclinical Research

Ethicon

As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.

Matt Wagener

VP of Clinical Operations,

Proxima Clinical Research, Inc.

As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.

Rod Bugawan, PharmD

Business Development Manager,

Novotech

As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.

Agenda

11:30am

Registration Opens and Networking Lunch

12:00pm–1:30pm

Presentations and Q&A

1:30pm–2:00pm

Panel Discussion: Messes and Successes of Preparing and Executing Your First Trial

2:00pm

Program Close

Sponsors

JLABS on Twitter

RSVPs are closed
Submit
Text goes here
X
Tickets closed
[confirmation_headline]
[confirmation_messaging]
Add to Calendar
Text goes here
X
CONTACT THE ORGANIZER
Google   Outlook   iCal   Yahoo
Sorry, ticket sales have closed.